Subclinical hypothyroidism, autoimmunity, and late obstetric outcomes: a population-based cohort study
The 2026 American Thyroid Association guidelines no longer use thyroid-antibody status to guide levothyroxine treatment in subclinical hypothyroidism (SCH), yet the relevance of SCH and thyroid autoimmunity to obstetric outcomes beyond early pregnancy has rarely been examined at population scale. We evaluated the assoc...